SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $153K invested in Scinai Immunotherapeutics in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9K
2
+$2.48K
3
+$71

Top Sellers

1
-$61.7K
2
-$28K
3
-$13K
4
Morgan Stanley
Morgan Stanley
New York
-$8.05K
5
TPWA
TRUE Private Wealth Advisors
Oregon
-$6.15K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$58K
2
$34K
3
$17K
4
$13K
5
$10K
6
$9K
7
$6K
8
$3K
9
$2K
10
$1K
11
–
12
–
13
–